Heron Therapeutics | HRTX - Ordinary Share Capital

Stock Price
1.20
Daily Change
-0.08 -5.91%
Monthly
-19.80%
Yearly
-28.01%
Q1 Forecast
2.71

Heron Therapeutics reported $1.52M in Ordinary Share Capital for its fiscal quarter ending in September of 2024.





Ordinary Share Capital Change Date
ALKERMES USD 165.1M 49K Sep/2025
Alnylam Pharmaceuticals USD 131.79M 130.49M Sep/2025
Amarin USD 20.8M 28K Sep/2025
ANI Pharmaceuticals USD 21.73M 21.73M Jun/2025
Anika Therapeutics USD 143K 1000 Mar/2025
Arrowhead Research USD 135.7M 2.44M Sep/2025
Eisai JPY 282.11M 1000 Dec/2025
Esperion Therapeutics USD 112K 11K Sep/2023
GlaxoSmithKline GBP 4.08B 49.43M Dec/2025
Heron Therapeutics USD 1.52M 14K Sep/2024
Insmed USD 212.58M 210.76M Sep/2025
Ligand Pharmaceuticals USD 20K 0 Mar/2025
Merck USD 2.49B 15.79M Sep/2025
Nektar Therapeutics USD 19K 0 Sep/2024
Neurocrine Biosciences USD 99.7M 700K Sep/2025
Omeros USD 611K 17K Dec/2023
Pacira USD 44.9M 44.85M Jun/2025
Regeneron Pharmaceuticals USD 105.3M 1.1M Sep/2025
Roche Holding CHF 795.62M 699.54K Dec/2025
Surmodics USD 716K 4K Sep/2024
Ultragenyx Pharmaceutical USD 96.44M 88K Sep/2025
Veracyte USD 78.67M 73K Sep/2025
Vertex Pharmaceuticals USD 254M 2.29M Sep/2025